SE0602446L - New use of known pharmacologically active chemical compositions - Google Patents
New use of known pharmacologically active chemical compositionsInfo
- Publication number
- SE0602446L SE0602446L SE0602446A SE0602446A SE0602446L SE 0602446 L SE0602446 L SE 0602446L SE 0602446 A SE0602446 A SE 0602446A SE 0602446 A SE0602446 A SE 0602446A SE 0602446 L SE0602446 L SE 0602446L
- Authority
- SE
- Sweden
- Prior art keywords
- pharmacologically active
- chemical compositions
- new use
- active chemical
- alpha
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 abstract 7
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 abstract 3
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 abstract 3
- 241000590002 Helicobacter pylori Species 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000006052 feed supplement Substances 0.000 abstract 1
- 229940037467 helicobacter pylori Drugs 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to Use of at least one member selected from the group consisting of alpha-ketoglutaric acid (AKG)5 pharmaceutically acceptable salts of alpha-ketoglutaric acid and amides of alpha-ketoglutaric acid for the manufacture of a pharmaceutical preparation or a food or feed supplement for the treatment or prophylaxis of diseases related to infection of pathogenic strains of Helicobacter pylori in birds and mammals, including man.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0602446A SE0602446L (en) | 2006-11-16 | 2006-11-16 | New use of known pharmacologically active chemical compositions |
PCT/EP2007/062333 WO2008058993A2 (en) | 2006-11-16 | 2007-11-14 | Use of alpha ketogluaric acid for the treatment of infection with h. pylori |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0602446A SE0602446L (en) | 2006-11-16 | 2006-11-16 | New use of known pharmacologically active chemical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0602446L true SE0602446L (en) | 2008-05-17 |
Family
ID=38814302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0602446A SE0602446L (en) | 2006-11-16 | 2006-11-16 | New use of known pharmacologically active chemical compositions |
Country Status (2)
Country | Link |
---|---|
SE (1) | SE0602446L (en) |
WO (1) | WO2008058993A2 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4919855B1 (en) * | 1970-10-06 | 1974-05-21 | ||
US8076373B2 (en) * | 2001-09-11 | 2011-12-13 | North Cell Pharmacetical | Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite |
SE0200256D0 (en) * | 2001-12-21 | 2002-01-29 | Gramineer Internat Ab | New composition, methods and use |
WO2006043336A1 (en) * | 2004-10-20 | 2006-04-27 | Kotobuki Pharmaceutical Co., Ltd. | Therapeutic or preventive composition for gastric mucosa disease |
US7803817B2 (en) * | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
US20100222282A1 (en) * | 2006-01-19 | 2010-09-02 | Entress Ab | Method of diagnosis and method of treatment |
PL226695B1 (en) * | 2006-07-03 | 2017-08-31 | Danuta Kruszewska | Agent for preventing and/or inhibiting the colonization of Helicobater pylori and its application |
-
2006
- 2006-11-16 SE SE0602446A patent/SE0602446L/en not_active Application Discontinuation
-
2007
- 2007-11-14 WO PCT/EP2007/062333 patent/WO2008058993A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2008058993A3 (en) | 2008-11-20 |
WO2008058993A2 (en) | 2008-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA33467B1 (en) | Primary drugs include insulin-linking facilities | |
MX2012007410A (en) | Novel antiviral compounds. | |
MX2011012122A (en) | Thiophene derivatives. | |
UA108363C2 (en) | IMINOTIADIASIADIOXIDE OXIDES AS BACE INHIBITORS, COMPOSITIONS THEREOF AND THEIR APPLICATIONS | |
SG166115A1 (en) | Pharmaceutical preparation containing meloxicam | |
UY32599A (en) | ABT-263 SOLID ORAL FORMULATION | |
UA105229C2 (en) | Pharmaceutical formulation | |
BRPI0414581A (en) | benzimidazole derivatives: preparation and pharmaceutical applications | |
MY158974A (en) | Prodrugs comprising an exendin linker conjugate | |
NO20043367L (en) | Oral pharmaceutical preparation | |
UA110013C2 (en) | APPLICATION OF THE COMPOSITION FOR THE TREATMENT OF BALL-MARI-HERE AND THE RELATED DISORDERS | |
MX344787B (en) | Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders. | |
UA93393C2 (en) | 1,3-dioxane carboxylic acids | |
IL193252A0 (en) | N-hydroxyacrylamide compounds | |
UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
WO2011151722A3 (en) | Methods and compositions for oral pharmaceutical therapy | |
SG178975A1 (en) | Indenone derivative and pharmaceutical composition comprising same | |
PH12019500618A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
WO2007144083A3 (en) | Ache-nmda combination wafer | |
EA201001108A1 (en) | TABLETS DISPENSABLE IN THE Mouth OF THE TABLET, CONTAINING THE BASIS OF THE ESCITALOPRAM, AND METHOD OF THEIR RECEIVING | |
MX2009008463A (en) | Bioavailable formulations of heterocyclic compounds. | |
TW200745155A (en) | Preparation of pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl)betulinic acid | |
TW200728281A (en) | Novel N-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions | |
BR0311642A (en) | Increased Release Sodium Divalproex Formulation | |
EA201101622A1 (en) | PEPTIDE PHARMACEUTICAL COMPOSITION, MEANS ON ITS BASIS FOR THE TREATMENT OF GASTRODUODENAL DISEASES CAUSED BY HELICOBACTER PYLORI, AND A METHOD OF ITS USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |